Biomass consumption and persistent COVID symptoms in patients with moderate and severe SARS-CoV-2 infection
DOI:
https://doi.org/10.20453/rmh.v36i4.5783Palavras-chave:
Post-Acute COVID-19 Syndrome, Biomass, COVID-19, respiratory symptoms and signs, DyspneaResumo
Biomass consumption causes COPD, but it is unknown if it is linked to Post-Acute COVID-19 Syndrome (PACS). Objective: To examine the association between biomass use and this syndrome in recovered patients from two hospitals in northern Peru. Methods: A descriptive, cross-sectional, exploratory study was carried out. A questionnaire collected sociodemographic data, respiratory symptoms, and biomass use. Results: The final sample consisted of 110 participants. PACS was more common in those aged 35-65 (87.8%) and in Piura (89.1%), occurring in 88.1% of 2021 cases; the median time from symptom onset to interview was 82 (IQR = 79-119) weeks; 97/110 (86.3%) developed PACS; of these, 31% had used biomass before COVID-19 (p = 0.332). Among patients with PACS, the prevalence of dyspnea, fatigue, and cough was 68.4%, 67.3%, and 45.3%, respectively. After COVID-19, 61.05% used salbutamol and 14.7% used home oxygen. In the final model: having had a tracheostomy (p = 0.011), ICU stay (p = 0.039), and the mention of “sequelae in the epicrisis” (p = 0.052) were associated with PACS; however, biomass use (p = 0.332) and years of use (p = 0.072) were not. Conclusion: No link was found between prior biomass use and the development of PACS. The frequency of PACS was high, with dyspnea being the most common symptom.
Downloads
Referências
COVID - Coronavirus Statistics - Worldometer [Internet]. [cited April 25, 2024]. Available in: https://www.worldometers.info/coronavirus/
MINSA. Sala de Situación Covid-19 en Piura. Semana Epidemiológica N°21-2023 [Internet]. 2023. Available in: https://covid19.minsa.gob.pe/sala_situacional.asp
OPS / OMS. Se acaba la emergencia por la pandemia, pero la COVID-19 continúa - OPS/OMS | Organización Panamericana de la Salud [Internet]. 2023 [cited April 25, 2024]. Available in: https://www.paho.org/es/noticias/6-5-2023-se-acaba-emergencia-por-pandemia-pero-covid-19-continua
National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE Guideline. Dec 18, 2020; [cited April 25, 2024]. Available in: https://www.nice.org.uk/guidance/ng188
Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM; Lifelines Corona Research Initiative. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022 Aug 6;400(10350):452-461. doi: 10.1016/S0140-6736(22)01214-4.
Bull-Otterson L, Baca S, Saydah S, et al. Post–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021. MMWR Morb Mortal Wkly Rep 2022;71:713–717. doi: 10.15585/mmwr.mm7121e1
Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun. 2022 Mar;101:93-135. doi: 10.1016/j.bbi.2021.12.020..
Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021 Jan 16;397(10270):220-232. doi: 10.1016/S0140-6736(20)32656-8.
Jain V, Yuan JM. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. Int J Public Health. 2020 Jun;65(5):533-46. doi: 10.1007/s00038-020-01390-7.
Po JYT, FitzGerald JM, Carlsten C. Respiratory disease associated with solid biomass fuel exposure in rural women and children: systematic review and meta-analysis. Thorax. 2011 Mar;66(3):232-9. doi: 10.1136/thx.2010.147884.
Kurmi OP, Semple S, Simkhada P, Smith WCS, Ayres JG. COPD and chronic bronchitis risk of indoor air pollution from solid fuel: a systematic review and meta-analysis. Thorax. marzo de 2010;65(3):221-8. doi: 10.1136/thx.2009.124644.
Biomass - MeSH - NCBI [Internet]. [cited Oct 3, 2025]. Disponible en: https://www.ncbi.nlm.nih.gov/mesh/?term=biomass
Torres-Duque C, Maldonado D, Pérez-Padilla R, Ezzati M, Viegi G, Forum of International Respiratory Studies (FIRS) Task Force on Health Effects of Biomass Exposure. Biomass fuels and respiratory diseases: a review of the evidence. Proc Am Thorac Soc. 2008 Jul 15;5(5):577-90. doi: 10.1513/pats.200707-100RP.
Sällsten G, Gustafson P, Johansson L, Johannesson S, Molnár P, Strandberg B, et al. Experimental wood smoke exposure in humans. Inhal Toxicol. 2006 Oct;18(11):855-64. doi: 10.1080/08958370600822391.
Banerjee A, Mondal NK, Das D, Ray MR. Neutrophilic inflammatory response and oxidative stress in premenopausal women chronically exposed to indoor air pollution from biomass burning. Inflammation. 2012 Apr;35(2):671-83. doi: 10.1007/s10753-011-9360-2.
World Health Organization. Fuel for life: household energy and health [Internet]. 2 Jan 2006. [cited 2025 Oct 1, 2025]. Available in: https://www.who.int/publications/i/item/9789241563161
INEI. Hogares en los que cocinan con combustibles contaminantes. [Internet]. 2019. Available in: https://www.inei.gob.pe/media/MenuRecursivo/publicaciones_digitales/Est/Lib1664/libro.pdf
Montaño M, Beccerril C, Ruiz V, Ramos C, Sansores RH, González-Avila G. Matrix metalloproteinases activity in COPD associated with wood smoke. Chest. 2004 Feb;125(2):466-72. doi: 10.1378/chest.125.2.466.
Nieman GF, Clark WR, Wax SD, Webb SR. The effect of smoke inhalation on pulmonary surfactant. Ann Surg. 1980 Feb;191(2):171-81. doi: 10.1097/00000658-198002000-00008.
Zelikoff JT, Chen LC, Cohen MD, Schlesinger RB. The toxicology of inhaled woodsmoke. J Toxicol Environ Health B Crit Rev. 2002;5(3):269-82. doi: 10.1080/10937400290070062.
Caballero A, Torres-Duque CA, Jaramillo C, Bolívar F, Sanabria F, Osorio P, et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest. 2008 Feb;133(2):343-9. doi: 10.1378/chest.07-1361.
Thakur M, Boudewijns EA, Babu GR, van Schayck OCP. Biomass use and COVID-19: A novel concern. Environ Res. 2020 Jul;186:109586. doi: 10.1016/j.envres.2020.109586.
Cui Y, Zhang ZF, Froines J, Zhao J, Wang H, Yu SZ, et al. Air pollution and case fatality of SARS in the People’s Republic of China: an ecologic study. Environ Health. 2003 Nov 20;2(1):15. doi: 10.1186/1476-069X-2-15.
Ciencewicki J, Jaspers I. Air Pollution and Respiratory Viral Infection. Inhal Toxicol. 2007 Nov;19(14):1135-46. doi: 10.1080/08958370701665434.
Wu X, Nethery RC, Sabath BM, Braun D, Dominici F. Exposure to air pollution and COVID-19 mortality in the United States: A nationwide cross-sectional study. medRxiv [Preprint]. 2020 Apr 7:2020.04.05.20054502. doi: 10.1101/2020.04.05.20054502.
León-Jiménez F, Vives-Kufoy C, Failoc-Rojas VE, Valladares-Garrido MJ, León-Jiménez F, Vives-Kufoy C, et al. Mortalidad en pacientes hospitalizados por COVID-19. Estudio prospectivo en el norte del Perú, 2020. Rev Méd Chile. 2021 Oct;149(10):1459-66. doi: 10.4067/s0034-98872021001001459
Matsuyama E, Miyata J, Terai H, Miyazaki N, Iwasaki T, Nagashima K, et.al. Chronic obstructive pulmonary disease, asthma, and mechanical ventilation are risk factors for dyspnea in patients with long COVID: A Japanese nationwide cohort study. Respir Investig. 2024 Nov;62(6):1094-1101. doi: 10.1016/j.resinv.2024.09.009.
Ortiz-Quintero B, Martínez-Espinosa I, Pérez-Padilla R. Mechanisms of Lung Damage and Development of COPD Due to Household Biomass-Smoke Exposure: Inflammation, Oxidative Stress, MicroRNAs, and Gene Polymorphisms. Cells. 2023 Jan;12(1):67. doi: 10.3390/cells12010067.
Honardoost M, Janani L, Aghili R, Emami Z, Khamseh ME. The Association between Presence of Comorbidities and COVID-19 Severity: A Systematic Review and Meta-Analysis. Cerebrovasc Dis. 2021;50(2):132-140. doi: 10.1159/000513288.
Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022 Aug;28(8):1706-14. doi: 10.1038/s41591-022-01909-w.
Díaz de León-Martínez L, de la Sierra-de la Vega L, Palacios-Ramírez A, Rodriguez-Aguilar M, Flores-Ramírez R. Critical review of social, environmental and health risk factors in the Mexican indigenous population and their capacity to respond to the COVID-19. Sci Total Environ. 2020 Sep 1;733:139357.doi: 10.1016/j.scitotenv.2020.139357.
Laurent R, Correia P, Lachand R, Diconne E, Ezingeard E, Bruna F, Guenier PA, Page D, Périnel-Ragey S, Thiéry G. Long-term outcomes of COVID-19 intensive care unit survivors and their family members: a one year follow-up prospective study. Front Public Health. 2023 Aug 8;11:1236990. doi: 10.3389/fpubh.2023.1236990.
Malik P, Patel K, Pinto C, Jaiswal R, Tirupathi R, Pillai S, Patel U. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis. J Med Virol. 2022 Jan;94(1):253-262. doi: 10.1002/jmv.27309.
Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re’em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021 Aug;38:101019. doi: 10.1016/j.eclinm.2021.101019.
Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021 Sep;18(9):e1003773. doi: 10.1371/journal.pmed.1003773.
Notarte KI, de Oliveira MHS, Peligro PJ, Velasco JV, Macaranas I, Ver AT, et al. Age, Sex and Previous Comorbidities as Risk Factors Not Associated with SARS-CoV-2 Infection for Long COVID-19: A Systematic Review and Meta-Analysis. J Clin Med. 2022 Dec 9;11(24):7314. doi: 10.3390/jcm11247314.
Danesh V, Arroliga AC, Bourgeois JA, Boehm LM, McNeal MJ, Widmer AJ, et al. Symptom Clusters Seen in Adult COVID-19 Recovery Clinic Care Seekers. J Gen Intern Med. 2023 Feb;38(2):442-9. doi:10.1007/s11606-022-07908-4.
Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, et al. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023 Jun 13;329(22):1934-46. doi:10.1001/jama.2023.8823.
Ponce de León Z. Sistema de Salud en el Perú y el COVID-19. Documento de política pública [Internet]. PUCP; 2021. Disponible en: https://gobierno.pucp.edu.pe/wp-content/uploads/2021/12/la-salud-en-tiempos-de-covid-vf.pdf
Yang J, Markus K, Andersen KM, Rudolph AE, McGrath LJ, Nguyen JL, et al. Definition and measurement of post-COVID-19 conditions in real-world practice: a global systematic literature review. BMJ Open. 2024 Jan 17;14(1):e077886. doi: 10.1136/bmjopen-2023-077886.
Sana A, Somda SMA, Meda N, Bouland C. Chronic obstructive pulmonary disease associated with biomass fuel use in women: a systematic review and meta-analysis. BMJ Open Respir Res. 2018 Jan 12;5(1):e000246. doi: 10.1136/bmjresp-2017-000246.
Bachelet VC, Carroza B, Morgado B, Silva-Ayarza I. A systematic analysis of the literature on the post-COVID-19 condition in Latin America focusing on epidemiology, clinical characteristics, and risk of bias. Medwave. 2025 Jan 16;25(1):e3014. English. doi: 10.5867/medwave.2025.01.3014.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2025 Los autores
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Os autores cedem os seus direitos à RMH para que estas possam divulgar o artigo através dos meios ao seu alcance. A revista fornecerá formulários de declaração de autoria e autorização para a publicação do artigo, que deverão ser entregues juntamente com o manuscrito. Os autores conservam o direito de partilhar, copiar, distribuir, executar e comunicar publicamente o seu artigo, ou parte dele, mencionando a publicação original na revista.
